Kymera Therapeutics, Inc.

Report date
12/31/2025
Quarter
2025 Q4
Filed
3/13/2026
Shares
7,474,747
Value ($000)
581,610
Weight
5.7%
2020 Q3 - 2025 Q4 (19 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).